Vanda Pharmaceuticals
VNDA
#7963
Rank
NZ$0.65 B
Marketcap
NZ$10.93
Share price
2.64%
Change (1 day)
35.25%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2025 (TTM): NZ-$2.43

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$2.50. In 2024 the company made an earnings per share (EPS) of NZ-$0.56 a decrease over its 2023 EPS that were of NZ$0.09219.

EPS history for Vanda Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$2.43332.22%
2024NZ-$0.56-710.9%
2023NZ$0.09219-56.35%
2022NZ$0.21-80%
2021NZ$1.06
2019NZ$3.82334%
2018NZ$0.88-247.06%
2017NZ-$0.60-19.05%
2016NZ-$0.74-55.32%
2015NZ-$1.65-347.37%
2014NZ$0.67-156.72%
2013NZ-$1.18-31.63%
2012NZ-$1.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.38-715.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.36-594.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31-192.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$49.68-2,087.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.26-350.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.27-350.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ-$7.73 209.15%๐Ÿ‡บ๐Ÿ‡ธ USA